已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes

医学 他汀类 不利影响 药方 回顾性队列研究 内科学 冲程(发动机) 队列研究 药理学 机械工程 工程类
作者
Huabing Zhang,Jorge Plutzky,Maria Shubina,Alexander Turchin
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:167 (4): 221-221 被引量:75
标识
DOI:10.7326/m16-0838
摘要

Many patients discontinue statin treatment, often after having a possible adverse reaction. The risks and benefits of continued statin therapy after an adverse reaction are not known.To examine the relationship between continuation of statin therapy (any prescription within 12 months after an adverse reaction) and clinical outcomes.Retrospective cohort study.Primary care practices affiliated with 2 academic medical centers.Patients with a presumed adverse reaction to a statin between 2000 and 2011.Information on adverse reactions to statins was obtained from structured electronic medical record data or natural-language processing of narrative provider notes. The primary composite outcome was time to a cardiovascular event (myocardial infarction or stroke) or death.Most (81%) of the adverse reactions to statins were identified from the text of electronic provider notes. Among 28 266 study patients, 19 989 (70.7%) continued receiving statin prescriptions after the adverse reaction. Four years after the presumed adverse event, the cumulative incidence of the composite primary outcome was 12.2% for patients with continued statin prescriptions, compared with 13.9% for those without them (difference, 1.7% [95% CI, 0.8% to 2.7%]; P < 0.001). In a secondary analysis of 7604 patients for whom a different statin was prescribed after the adverse reaction, 2014 (26.5%) had a documented adverse reaction to the second statin, but 1696 (84.2%) of those patients continued receiving statin prescriptions.The risk for recurrent adverse reactions to statins could not be established for the entire sample. It was also not possible to determine whether patients actually took the statins.Continued statin prescriptions after an adverse reaction were associated with a lower incidence of death and cardiovascular events.Chinese National Key Program of Clinical Science, National Natural Science Foundation of China, and Young Scientific Research Fund of Peking Union Medical College Hospital.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
橘生淮南.发布了新的文献求助10
2秒前
脑洞疼应助shawwcus采纳,获得10
2秒前
3秒前
jixieshiren完成签到,获得积分10
4秒前
bkagyin应助吃醋的喵酱采纳,获得10
5秒前
万能图书馆应助冲鸭采纳,获得30
5秒前
6秒前
萤火虫果果完成签到,获得积分10
6秒前
香蕉觅云应助活泼学生采纳,获得10
10秒前
雪风完成签到 ,获得积分10
12秒前
12秒前
12秒前
13秒前
CodeCraft应助xiaoran采纳,获得10
14秒前
15秒前
18秒前
silence发布了新的文献求助10
18秒前
21秒前
Remember完成签到,获得积分10
21秒前
21秒前
炒栗子发布了新的文献求助10
23秒前
mafukairi应助amber采纳,获得10
23秒前
本墨发布了新的文献求助10
25秒前
卡思完成签到,获得积分10
25秒前
Remember发布了新的文献求助10
25秒前
27秒前
silence完成签到,获得积分20
27秒前
iyNew_xx完成签到,获得积分10
27秒前
顾矜应助YOYO采纳,获得30
29秒前
30秒前
独徙完成签到 ,获得积分10
31秒前
烟花应助炒栗子采纳,获得10
33秒前
种喜欢的花完成签到 ,获得积分10
36秒前
yan发布了新的文献求助10
38秒前
多情元灵完成签到,获得积分10
41秒前
48秒前
小二郎应助ACS副主编采纳,获得10
49秒前
49秒前
氪金读书完成签到,获得积分10
49秒前
羊村村长发布了新的文献求助20
51秒前
高分求助中
求国内可以测试或购买Loschmidt cell(或相同原理器件)的机构信息 1000
The Heath Anthology of American Literature: Early Nineteenth Century 1800 - 1865 Vol. B 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Machine Learning for Polymer Informatics 500
《关于整治突出dupin问题的实施意见》(厅字〔2019〕52号) 500
2024 Medicinal Chemistry Reviews 480
Women in Power in Post-Communist Parliaments 450
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3219517
求助须知:如何正确求助?哪些是违规求助? 2868333
关于积分的说明 8160589
捐赠科研通 2535388
什么是DOI,文献DOI怎么找? 1367808
科研通“疑难数据库(出版商)”最低求助积分说明 645094
邀请新用户注册赠送积分活动 618441